Skip to content

NACDS praises Labor Department rule requiring PBMs to disclose their compensation

Employers could better hold PBMs accountable with a clearer picture of how they are paid, including rebates, fees, spread pricing and what PBMs actually reimburse pharmacies.

ARLINGTON, Va. — The National Association of Chain Drug Stores (NACDS) welcomed a new Department of Labor rule requiring pharmacy benefit managers to disclose how much self-insured employer health plans pay them. The group also urged regulators to enforce the rule.

The final rule applies to self-insured health plans governed by ERISA, the federal law regulating employer benefit plans. PBMs must disclose their compensation to plan sponsors and fiduciaries, tell employers up front how much they expect to earn, and provide updates every six months. Plan sponsors can audit these disclosures annually using an auditor of their choice.

"NACDS commends the Department of Labor for finalizing this rule – another important aspect of the comprehensive reforms that are needed," said Steve Anderson, president and chief executive of NACDS. He said the rule gives employers, who are legally responsible for ensuring their PBM contracts are reasonable, the information they need to meet that obligation.

Anderson said chain pharmacies see the issue "from both sides”: NACDS member companies employ nearly 3 million people and sponsor their own health plans, while also working every day within what he called "opaque PBM networks and reimbursement systems."

He said employers could better hold PBMs accountable with a clearer picture of how they are paid, including rebates, fees, spread pricing and what PBMs actually reimburse pharmacies. Without that transparency, Anderson said, health benefit dollars can disappear “into the convoluted compensation structure of vertically integrated plans and PBMs” instead of paying for employees’ care and medications.

He also cautioned that disclosure alone is not enough. “Transparency is only as strong as its enforcement,” Anderson said. He noted that vertically integrated plans and PBMs have “a long record of resisting federal and state oversight.” NACDS urged the Labor Department to pair the rule with strong enforcement to ensure fairer treatment for employers, employees, and pharmacies.

The rule was also cheered by the National Community Pharmacists Association. “The employers who pay PBMs to administer their health plans have been kept in the dark for many years when it comes to these fees and other forms of compensation. This new rule creates additional transparency for the first time,” said Ronna Hauser, NCPA’s senior vice president of policy and pharmacy affairs.

The new rule complements provisions included in the Consolidated Appropriations Act of 2026 and follows an executive order by President Donald Trump, “Lowering Drug Prices Once Again Putting Americans First.” NCPA strongly supported both measures.

NCPA said that recognition of how PBMs are actually paid will enable employers and their fiduciaries to negotiate contracts and seek lower prescription drug costs for workers and their families. The rule is projected by the DOL to lower prescription drug costs by as much as $22 billion over 10 years. 

NCPA attended the announcement Thursday at the DOL, where Assistant Secretary Daniel Aronowitz told PBMs that “the jig is up.” He noted that prescription drugs are the fastest growing part of an employer’s health care coverage, and that due to misaligned and conflicting financial incentives, PBM revenues grow when insurance plans spend more. As an example, he cited a particular drug costing $5.25 at the pharmacy counter that is charged to the plan for $84 — 16 times the cost. “The patient at the counter needs more than rebates. She needs medicine she can afford,” he said.

Submit Your Press Release

Have news to share? Send us your press releases and announcements.

Send Press Release

Latest